Company Overview and News
DCM Shriram, Godawari Power and Ispat, Gruh Finance, Hindustan Oil Exploration, JIK Industries, Lux Industries, Omax Autos and Pudumjee Pulp will announce their results on Saturday for the quarterly period ended December 2017. While Aro Granites will declare its Q3 results on Sunday, about two dozen firms such as Asian Paints, Axis Bank, JustDial, Dewan Housing, Havells, GNFC, Rallis India, Tinplate, Vagrangee and V-Guard will declare on Monday.
Mumbai: The Tata group has hired EY to explore the sale of Tata Petrodyne Ltd (TPL), its oil and gas exploration and production business, two people aware of the development said.
Hindustan Oil Exploration Company (HOEC) is expecting its production to go up from 500 barrels of oil equivalent during 2015 to around 8,000 barrels during the current fiscal year, backed by the growing production in its Assam facility. The company, which has been facing crisis after shutting down one of its facility in 2011, is expecting its three ongoing projects to take up the production to 25,000 barrels in three to five years, said P Elango, MD of the company.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
New Delhi : State-owned ONGC and Vedanta Ltd on Wednesday emerged as the biggest bidders for oil and gas blocks, putting in 41 out of 56 bids received in India’s maiden auction under open acreage licensing regime.
Hindustan Oil Exploration Co Ltd (HOEC) has submitted a USD 43-million development plan to bring to production the Mumbai offshore oil field it had won in the first discovered field auction in March.
Hindustan Oil Exploration Company (HOEC) is in a sweet spot with projects being implemented on time and greater visibility on monetization of assets in the coming quarters. With the government announcing the second stage of auction of discovered small fields and putting forth a proposal to allow private firms to bid for a majority stake, HOEC stands well positioned to benefit from these measures.
The share price of Hindustan Oil Exploration Company (HOEC) reached a year-high of ₹119.40 before closing at ₹111.15 on the BSE, thanks primarily to the rise in prices of Brent crude, which has raced past the $64-mark a barrel. HOEC’s rise is due to the sentiment attached to higher crude prices — the company does not produce oil but only natural gas whose prices are fixed.
Close to two dozen companies will announce their results for the July-September period on Saturday. Among these are Adani Transmission, Agri-Tech (India), Andhra Sugars, Aro Granite, CDSL, Bhageria Industries, Bharat Financial Inclusion, Hindustan Oil Exploration, Jubilant Life Sciences, Jayant Agro Organics, ONGC, Nath Bio-Genes, Seshasayee Paper, Shriram Pistons, Techindia Nirman and TRF. Shares of these companies will react based on their financial performance.
Hindustan Oil Exploration Company (HOEC) has been buzzing and has gained 45 percent this year so-far and 14 percent this month. In an interview to CNBC-TV18, P Elango, MD of the company spoke about the latest happenings and his outlook going ahead.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...